(Q80351047)
Statements
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration (English)
Macugen AMD Study Group
Rajendra S Apte
Marlene Modi
Harvey Masonson
Manju Patel
Lloyd Whitfield
Anthony P Adamis